CLINICAL HIGH RISK FOR PSYCHOSIS
Clinical trials for CLINICAL HIGH RISK FOR PSYCHOSIS explained in plain language.
Never miss a new study
Get alerted when new CLINICAL HIGH RISK FOR PSYCHOSIS trials appear
Sign up with your email to follow new studies for CLINICAL HIGH RISK FOR PSYCHOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can eye games sharpen the mind in schizophrenia?
Disease control Not yet recruitingThis trial investigates whether a gamified eye-movement training program can improve cognitive function in people across different stages of schizophrenia, including those at clinical high risk. Participants will be randomly assigned to either eye-movement training or a finger-co…
Matched conditions: CLINICAL HIGH RISK FOR PSYCHOSIS
Phase: NA • Sponsor: Shanghai Mental Health Center • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
CBD trial aims to stop psychosis before it starts
Symptom relief Not yet recruitingThis study tests whether cannabidiol (CBD), a non-psychoactive cannabis compound, can reduce psychotic symptoms in 586 young people (ages 12-35) at high risk for psychosis. Participants take either CBD or a placebo daily for two years. The goal is to see if CBD can ease symptoms …
Matched conditions: CLINICAL HIGH RISK FOR PSYCHOSIS
Phase: PHASE3 • Sponsor: University of Oxford • Aim: Symptom relief
Last updated Jun 27, 2026 09:08 UTC